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JNK protein kinases are distantly related to mitogen-activated protein kinases (ERKs) and are activated by
dual phosphorylation on Tyr and Thr. The JNK protein kinase group includes the 46-kDa isoform JNK1. Here
we describe the molecular cloning of a second member of the JNK group, the 55-kDa protein kinase JNK2. The
activities of both JNK isoforms are markedly increased by exposure of cells to UV radiation. Furthermore, JNK
protein kinase activation is observed in cells treated with tumor necrosis factor. Although both JNK isoforms
phosphorylate the NH2-terminal activation domain of the transcription factor c-Jun, the activity of JNK2 was
approximately 10-fold greater than that of JNK1. This difference in c-Jun phosphorylation correlates with
increased binding of c-Jun to JNK2 compared with JNK1. The distinct in vitro biochemical properties of these
JNK isoforms suggest that they may have different functions in vivo. Evidence in favor of this hypothesis was
obtained from the observation that JNK1, but not JNK2, complements a defect in the expression of the
mitogen-activated protein kinase HOG1 in the yeast Saccharomyces cerevisiae. Together, these data indicate a
role for the JNK group of protein kinases in the signal transduction pathway initiated by proinflammatory
cytokines and UV radiation.
Tumor necrosis factor alpha (TNF-oa) was discovered as a
factor in the serum of mice injected with bacillus Calmette-
Guerin (Mycobacterium bovis BCG) or lipopolysaccharide that
induced tumor necrosis in tumor-bearing mice (16). A similar
factor, TNF-3 (lymphotoxin), was discovered as a soluble
factor released from the lymph node T cells of immunized rats
that shows cytolytic activity toward murine L929 fibroblasts
(59). Subsequent studies have led to the molecular cloning of
the two related factors, TNF-ot and TNF-13, that have similar
actions in vivo and in vitro (26). These TNFs are potent
cytokines that elicit a large number of biological effects,
including hemorrhagic necrosis of transplanted tumors, cyto-
toxicity, immunoregulation, cellular proliferation, antiviral re-
sponses, and transcriptional activation of many genes (9, 24,
26). In particular, TNF-ao has an important role in the inflam-
matory response and is a principal mediator of toxic shock and
sepsis.
The primary source of TNF-ot is the activated macrophage
or monocyte, while activated T cells represent the major source
of TNF-4. Although these factors are released from different
cell types, both TNF-ot and TNF-r3 bind to the same two cell
surface receptors (55 and 75 kDa) that are widely expressed in
the tissues of the body (70). The extracellular domains of these
receptors share 28% homology and are divided into four
repeating Cys-rich domains, similar to the low-affinity nerve
growth factor receptor, Fas antigen, CD40, OX40, and CD27
(68). In contrast, the cytoplasmic domains of the two TNF
receptors have no obvious homology to each other (70). This
has led to some controversy about the role of each receptor
(34, 72). However, a consensus view is that the 55-kDa
receptor mediates cytotoxicity, antiviral activity, fibroblast pro-
liferation, and transcription factor activation (13, 21, 22, 47,
68-70, 72, 73, 76, 77). The 75-kDa receptor may mediate a
distinct signaling role (35, 42). Alternatively, the 75-kDa
* Corresponding author.
receptor may act as a coreceptor that presents TNF for binding
the 55-kDa signaling receptor (71).
The structure of TNF bound to the 55-kDa receptor has
been determined by X-ray crystallography to consist of three
receptor molecules bound symmetrically to one TNF-f3 trimer
(8). This structure suggests that TNF-induced aggregation of
the 55-kDa receptor may represent an initial step in the signal
transduction mechanism. Interestingly, ligand-induced aggre-
gation has been established to account for the activation of
tyrosine kinase receptors (60). Receptor aggregation may
therefore be a common mechanism of activation of several
classes of cell surface receptors.
The mechanism of signal transduction by TNF receptors is
poorly understood. However, it is likely that the TNF signaling
mechanism is similar to that of the proinflammatory cytokine
interleukin-1 (IL-1). Both of these cytokines cause marked
activation of transcription factors AP-1 and NF-KB (14, 46,51).
In addition, the analysis of cellular phosphoproteins by two-
dimensional gel electrophoresis demonstrates that TNF and
IL-1 cause increased phosphorylation of a common group of at
least 53 proteins and decreased phosphorylation of 10 addi-
tional proteins (31). Treatment of cells with other cytokines
does not regulate the phosphorylation of the same group of
proteins, indicating that TNF may activate a distinct signal
transduction pathway. Examples of TNF-stimulated phosphor-
ylation include the 27- to 28-kDa small heat shock proteins, the
28-kDa mRNA cap-binding protein, the epidermal growth
factor (EGF) receptor, eIF-4E, 1-plastin, myosin light chain,
nucleolin, stathmin, c-Abl, Rb, and p53 (11, 29-31, 55).
Several kinase activities have been reported to be increased
by TNF and IL-1. These include well-defined protein kinases,
such as protein kinase A (64, 79), protein kinase C (14, 53),
and mitogen-activated protein (MAP) kinases (ERKs) (28, 31,
57, 74). As these protein kinases have been implicated in the
mechanisms of signal transduction by many other extracellular
stimuli, it is difficult to understand how the activation of these
kinases can account for the distinctive pattern of protein
phosphorylation that is induced by TNF (31). Therefore, there
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has been much interest in the role of novel protein kinases.
Indeed, several protein kinase activities that are increased by
treatment of cells with proinflammatory cytokines have been
identified: a ceramide-activated protein kinase (20, 40, 48, 49),
an hsp27 kinase (28), a P-casein kinase (28), an 85-kDa nuclear
kinase (56), and tyrosine kinase activity (37, 40). However,
these activities have not been molecularly characterized.
The purpose of this study was to investigate whether JNK
protein kinases are activated in TNF-treated cells. Two JNK
protein kinase isoforms (46 and 55 kDa) have been identified
in HeLa cells (36). Recently, we described the molecular
cloning of the 46-kDa isoform, JNK1 (18). In this report, we
describe the cloning of the 55-kDa isoform, JNK2. In addition,
we show that TNF, like UV radiation, causes JNK protein
kinase activation. The activation of transcription factor AP-1
caused by UV radiation is similar to that caused by proinflam-
matory cytokines (14, 19, 51). The effect on AP-1 can be
accounted for by the JNK protein kinase pathway and the
phosphorylation of c-Jun within the NH2-terminal activation
domain (18, 36). We conclude that JNK protein kinases
represent an important signaling pathway that mediates ac-
tions of proinflammatory cytokines and UV radiation.
MATERIALS AND METHODS
Materials. [32P]phosphate was purchased from Dupont-
NEN. [y-32P]ATP was prepared with a Gamma-Prep A kit
(Promega Biotec) as described by the manufacturer. Monoclo-
nal antibody M2, which binds the epitope Asp-Tyr-Lys-Asp-
Asp-Asp-Asp-Lys, was purchased from IBI-Kodak. Recombi-
nant glutathione S-transferase (GST) fusion proteins with
c-Jun and v-Jun have been described previously (18). Recom-
binant human TNF-a was obtained from Genzyme Corp. The
polyclonal rabbit JNK antibody was prepared using bacterially
expressed JNK1 as an antigen.
Molecular cloning and hybridization analysis. A random-
primed probe prepared from the JNK1 cDNA (18) was used to
screen a XZapII HeLa cDNA library (Stratagene Inc. no.
936201). Three positive clones were obtained after screening
106 phage. DNA sequencing of both strands of each clone was
performed by using a PCR procedure employing fluorescent
dideoxynucleotides and a model 373A automated sequencer
(Applied Biosystems). This analysis demonstrated that these
clones corresponded to overlapping cDNAs and included the
complete JNK2 coding region.
The JNK2 cDNA was cloned into the expression vector
pCMV5 (6) between the XbaI and HindIII sites. A PCR-based
procedure was used to insert an epitope tag (Asp-Tyr-Lys-Asp-
Asp-Asp-Asp-Lys) between codons 1 and 2 of the JNK1 cDNA
(37). The sequence of each of these constructs was confirmed
by automated sequencing with a model 373A DNA sequencer
(Applied Biosystems).
Northern (RNA) blots were performed with 2 ,ug of
poly(A)+ RNA isolated from different human tissues, fraction-
ated by denaturing agarose gel electrophoresis, and transferred
onto a nylon membrane (Clontech). The blots were hybridized
to probes prepared by labeling fragments of JNK1 (bp 936 to
1418) and JNK2 (bp 1270 to 1736) cDNAs with [cX-32P]dCTP
(Amersham International PLC) by random priming (Strat-
agene Inc.). The integrity of the mRNA samples was confirmed
by hybridization to an actin probe. The blots were washed
three times with lx SSC (0.15 M NaCl plus 0.015 M sodium
citrate)-0.05% sodium dodecyl sulfate (SDS)-1 mM EDTA
prior to autoradiography.
Tissue culture. HeLa and COS-1 cells were obtained from
the American Type Culture Collection and were maintained in
Dulbecco's modified Eagle's medium supplemented with 5%
(vol/vol) fetal bovine serum (Gibco-BRL). Transient transfec-
tion of COS-1 cells was performed by using 1 jig of plasmid
DNA as described previously (62).
In vitro translation. Plasmids (pBluescript) containing
JNK1 and JNK2 cDNAs were linearized with BamHI and
transcribed with T7 polymerase in vitro (Promeqa Biotec). In
vitro translation was performed by using [35S]methionine
(Dupont-NEN) and reticulocyte lysate (Promega Biotec).
Binding assays. Binding assays were performed by incubat-
ing the JNK protein kinases with 5 jig of GST-Jun in 250 RIl of
buffer A (20 mM Tris [pH 7.4], 137 mM NaCl, 2 mM EDTA,
1% Triton X-100, 10% glycerol, 2mM pyrophosphate, 25 mM
P-glycerophosphate, 10 jig of leupeptin per ml, 100 jiM
phenylmethylsulfonyl fluoride). The complexes were collected
with 10 ,u of glutathione (GSH)-agarose and washed three
times with 20mM N-2-hydroxyethylpiperazine-N'-2-ethanesul-
fonic acid (HEPES; pH 7.4)-50 mM NaCl-0.1 mM EDTA-25
mM MgCl2-0.05% Triton X-100. A fraction of the total JNK
(10%) and the bound JNK were detected after SDS-polyacryl-
amide gel electrophoresis (PAGE). Epitope-tagged JNK was
detected by Western blot (immunoblot) analysis. In vitro-
translated JNK was detected by autoradiography (Kodak X-
Omat AR film) and quantitated by PhosphorImager (Molec-
ular Dynamics Inc.) analysis. The efficiency of binding was
calculated as the percentage of total JNK in the incubation that
bound to GST-Jun.
Protein kinase assays. Immune-complex kinase assays using
monoclonal antibody M2 or the JNK polyclonal antibody were
performed by using GST-Jun as a substrate (18). Phosphory-
lation assays were performed in 50 RI of kinase buffer (10 mM
MgCl2-25 mM HEPES [pH 7.4] with 50 jiM [y-32P]ATP [10
,uCi/nmol]). The phosphorylation reactions were terminated
after 10 min by the addition of Laemmli sample buffer. The
phosphorylated proteins were resolved by SDS-PAGE, visual-
ized by autoradiography, and quantitated by Phosphorlmager
(Molecular Dynamics Inc.) analysis. Control experiments dem-
onstrated that the phosphorylation reactions were linear with
time for at least 40 min. Phosphoamino acid analysis and
tryptic peptide mapping were performed as described previ-
ously (18).
Western. blot analysis. Immunoblotting was performed by
using Immobilon-P membranes (Millipore Corp.), probing
with monoclonal antibody M2, and enhanced chemilumines-
cence detection (Amersham Inc.) as described previously (18).
Complementation assays. The HOG1 expression vector
pJB17 and Saccharomyces cerevisiae JBY10 (null mutant hogl-
Al) were obtained from M. Gustin (15). Expression vectors for
JNK1 and JNK2 were constructed by subcloning the cDNAs at
the BamHI and HindIII sites of pVP16 (75). The structure of
each plasmid was confirmed by automated sequencing with an
Applied Biosystems model 373A machine. Strain JBY10 was
transformed with the plasmids, and equal portions were spread
on agar plates supplemented without and with 0.9 M NaCl.
Expression of JNK1 and JNK2 in the yeast cells was confirmed
in control experiments by Western blot analysis.
Nucleotide sequence accession number. The sequence of the
human JNK2 cDNA has been deposited in the GenBank
database with accession number L31951.
RESULTS
The JNK group of protein kinases includes JNK1 and
JNK2. We have identified a 46-kDa protein kinase as a
member of the JNK protein kinase group (18). To identify
additional members of this group, we screened a HeLa cDNA
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A.
ATG AGC GAC AGT AAA TGT GAC AGT CAG TTT TAT AGT
M S D S K C D S Q F Y S
CAG CAG CTG AAA CCA ATT GGC TCT GGG GCC CAA GGG
Q Q L K P I G S G A Q G
GCA GTC AAG AAA CTA AGC CGT CCT TTT CAG AAC CAA
A V K K L S R P F Q N Q
TGT GTC AAT CAT AAA AAT ATA ATT AGT TTG TTA AAT
C V N H K N I I S L L N
TAT TTG GTT ATG GAA TTA ATG GAT GCT AAC TTA TGT
Y L V M E L M D A N L C
CTT CTT TAC CAG ATG CTT TGT GGT ATT AAA CAT CTG
L L Y Q M L C G I K H L
ATT GTT GTG AAA TCA GAC TGC ACC CTG AAG ATC CTT
I V V K S D C T L K I L
ACC CCT TAC GTG GTG ACA CGG TAC TAC CGG GCG CCC
T P Y V V T R Y Y R A P
TGG TCA GTG GGT TGC ATC ATG GGA GAG CTG GTG AAA
W S V G C I M G E L V K
AAT AAA GTT ATT GAG CAG CTG GGA ACA CCA TCA GCA
N K V I E Q L G T P S A
GAA AAC AGA CCA AAG TAT CCT GGA ATC AAA TTT GAA
E N R P K Y P G I K F E
GAC AAA ATA AAA ACA AGT CAA GCC AGA GAT CTG TTA
D K I K T S Q A R D L L
GAC GAA GCT CTG CGT CAC CCA TAC ATC ACT GTT TGG
D E A L R H P Y I T V W
GAT GCC CAG TTG GAA GAA AGA GAA CAT GCA ATT GAA
D A Q L E E R E H A I E
GAA AGA AGC AAG AAT GGT GTT GTA AAA GAT CAG CCT
E R S K N G V V K D Q P
TCA TCG ATC AAT GAC ATT TCA TCC ATG TCC ACT GAG
S S I N D I S S M S T E
GCGGGCGAGGGATCTGAAACTTGCCCACCCTTCGGGATATTGCAGGACGCTGCATC
GTG CAA GTG GCA GAC TCA ACC TTC ACT GTC CTA AAA CGT TAC
V Q V A D S T F T V L K R Y
ATT GTT TGT GCT GCA TTT GAT ACA GTT CTT GGG ATA AGT GTT
I V C A A F D T V L G I S V
ACT CAT GCA AAG AGA GCT TAT CGT GAA CTT GTC CTC TTA AAA
T H A K R A Y R E L V L L K
GTG TTT ACA CCA CAA AAA ACT CTA GAA GAA TTT CAA GAT GTG
V F T P Q K T L E E F Q D V
CAG GTT ATT-CAC ATG GAG CTG GAT CAT GAA AGA ATG TCC TAC
Q V I H M E L D H E R M S Y
CAT TCA GCT GGT ATA ATT CAT AGA GAT TTG AAG CCT AGC AAC
H S A G I I H R D L K P S N
GAC TTT GGC CTG GCC CGG ACA GCG TGC ACT AAC TTC ATG ATG
D F G L A R T A C T N F M M
GAA GTC ATC CTG GGT ATG GGC TAC AAA GAG AAC GTT GAT ATC
E V I L G M G Y K E N V D I
GGT TGT GTG ATA TTC CAA GGC ACT GAC CAT ATT GAT CAG TGG
G C V I F Q G T D H I D Q W
GAG TTC ATG AAG AAA CTT CAG CCA ACT GTG AGG AAT TAT GTC
E F M K K L Q P T V R N Y V
GAA CTC TTT CCA GAT TGG ATA TTC CCA TCA GAA TCT GAG CGA
E L F P D W I F P S E S E R
TCA AAA ATG TTA GTG ATT GAT CCT GAC AAG CGG ATC TCT GTA
S K M L V I D P D K R I S V
TAT GAC CCC GCC GAA GCA GAA GCC CCA CCA CCT CAA ATT TAT
Y D P A E A E A P P P Q I Y
GAA TGG AAA GAG CTA ATT TAC AAA GAA GTC ATG GAT TGG GAA
E W K E L I Y K E V M D W E
TCA GAT GCA GCA GTA AGT AGC AAC GCC ACT CCT TCT CAG TCT
S D A A V S S N A T P S Q S
CAG ACG CTG GCC TCA GAC ACA GAC AGC AGT CTT GAT GCC TCG
Q T L A S D T D S S L D A S
(1307) ACG GGA CCC CTT GAA GGC TGT CGA IgA TAGGTTAGAAATAGCAAACCTGTCAGCATTGAAGGAACTCTCACCTCCGTGGGCCTGAAATGCTTGG
(417) T G P L E G C R t
(1401) GAGTTGATGGAACCAAATAGAAAAACTCCATGTTCTGCATGTAAGAAACACAATGCCTTGCCCTATTCAGACCTGATAGGATTGCCTGCTTAGATGATAAAAT
(1504) GAGGCAGAATATGTCTGAAGAAAAAAATTGCAAGCCACACTTCTAGAGATTTTGTTCAAGATCATTTCAGGTGAGCAGTTAGAGTAGGTGAATTTGTTTCAAA
(1607) TTGTACTAGTGACAGTTTCTCATCATCTGTAACTGTTGAGATGTATGTGCATGTGACCACAAATGCTTGCTTGGACTTGCCCATCTAGCACTTTGGAAATCAG(1710) TATTTAAATGCCAAATAATCTTCCAGGTAGTGCTGCTTCTGAAGTTATCTCTTAATCCTCTTAAGTAATTT
B.
I II III IV
JNK2 MSDSKCDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGISVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQD
JNK1 ..R. .R.NN ... EIG. N.Y.AI.ERN. I........ M. G. S.
V VIA VIB VII * * VIII
JNK2 VYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENV
JNK1 ..I . Q..........G.S.
Ix x XI
JNK2 DIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMKKLQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKR
JNK1 L........M.CHKIL.P.R.Y. CP. . A. .S. .K .VL. .AD. .HN.. A. AS..
JNK2 ISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMDWEERSKNGVWKDQPSDAAVSSNATPSQSSSINDISSMSTEQTLASDTDSS
JNK1 . Q... .N. S. P.K. .......T . L.... Q... T .L IRG.. PL.QVQQ*
LDASTGPLEGCR*
FIG. 1. Identification of JNK2 as a member of the JNK protein kinase group. (A) Nucleotide and deduced protein sequences of the JNK2
cDNA. In-frame stop codons in the 5' and 3' untranslated regions are underlined. (B) Deduced sequence of JNK2 aligned with the JNK1 sequence,
using the PILEUP program (Wisconsin Genetics Computer Group). Residues that are identical are indicated with periods. The carboxyl termini
encoded by stop codons in the cDNA sequence are indicated (t). The protein kinase subdomains located within the deduced protein sequence are
illustrated, and the conserved tyrosine and threonine phosphorylation sites are indicated with asterisks (18).
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A. Western Blot Analysis
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B. Protein Kinase Assay
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w- c-Jun
JNK1
FIG. 2. UV radiation activates JNK protein kinases. Epitope-
tagged JNK1 and JNK2 proteins were expressed in COS cells. Mock-
transfected cells were used in control experiments. The cells were
either exposed or not exposed to 80 J of UV-C per m2 and incubated
for 1 h at 37°C. The JNK protein kinases were isolated by immuno-
precipitation with monoclonal antibody M2 and SDS-PAGE. The level
of expression of JNK protein kinases was examined by Western blot
analysis using monoclonal antibody M2 and enhanced chemilumines-
cence detection (A). JNK protein kinase activity was measured with an
immune-complex kinase assay and GST-Jun (residues 1 to 79) as the
substrate (B). Locations of molecular mass standards are shown at the
left in kilodaltons.
library cloned in the vector XZapII (106 plaques). Three
positive clones were identified. DNA sequence analysis re-
vealed that these clones corresponded to overlapping cDNAs.
The sequence of the largest clone (1,782 bp) contained the
complete open reading frame of a protein kinase (JNK2) that
is similar to JNK1 (Fig. 1). Comparison of the nucleotide
sequences of JNK1 and JNK2 indicates that these protein
kinases are the products of distinct genes. However, compar-
ison of the deduced protein sequence of JNK1 and JNK2
indicates a high level of sequence identity within the protein
kinase domain (Fig. 1B). Significantly, these JNK isoforms
share the Thr-183-Pro-Tyr-185 motif that corresponds to the
activating Thr and Tyr phosphorylation sites of JNK1 (18).
Several amino acid differences between JNK1 and JNK2 are
located within the kinase domain. However, the most obvious
difference between these protein kinases is that JNK2 has a
larger COOH-terminal extension than JNK1 (Fig. 1B).
To examine the expression of the JNK isoforms, we per-
formed Northern blot analysis of mRNA isolated from differ-
ent human tissues. Isoform-specific probes were prepared from
nonhomologous regions of the JNK1 and JNK2 cDNAs (3'
untranslated region). A low level of expression of JNK1 and
JNK2 was observed in human brain, heart, kidney, lung,
pancreas, and skeletal muscle (data not shown). Together,
these data indicate that the JNK1 and JNK2 protein kinases
are widely expressed in human tissues.
FIG. 3. Phosphorylation of c-Jun on Ser-63 and Ser-73 by JNK
protein kinases. Epitope-tagged JNK1 and JNK2 proteins were ex-
pressed in COS cells. The cells were exposed to 80 J of UV-C per m2
and incubated for 1 h at 370C. The JNK protein kinases were isolated
by immunoprecipitation with monoclonal antibody M2. An immune-
complex kinase assay was performed with recombinant c-Jun as a
substrate. The phosphorylated c-Jun was analyzed by phosphoamino
acid analysis (A) and tryptic phosphopeptide mapping (B). The origin
of each peptide maps is illustrated with a cross at the lower left corner
of each map. The horizontal dimension was electrophoresis, and the
vertical dimension was chromatography.
Activation of JNK protein kinases by UV radiation. We
expressed epitope-tagged JNK1 and JNK2 protein kinases in
COS cells. Western blot analysis demonstrated the presence of
the 46-kDa JNK1 and the 55-kDa JNK2 isoforms (Fig. 2A). A
higher level of expression of JNK1 than of JNK2 was observed
in the transient transfection assays. This difference in the level
of expression was confirmed in control experiments by immu-
noprecipitation of the JNK isoforms from cells metabolically
labeled with [35S]methionine (data not shown).
JNK protein kinase activity was measured by immunopre-
cipitation of the recombinant JNK proteins with monoclonal
antibody M2. It was found that both JNK isoforms phosphor-
ylated the NH2-terminal activation domain of c-Jun (Fig. 2B).
Exposure of the cells to UV radiation caused a marked
increase in JNK protein kinase activity. Interestingly, the
phosphorylation of c-Jun caused by JNK2 was more efficient
than that caused by JNK1. Quantitation of these data by
Phosphorlmager analysis demonstrated that the specific activ-
ity of JNK2 was approximately 10-fold greater than that of
JNK1.
JNK1 and JNK2 protein kinases phosphorylate c-Jun at
Ser-63 and Ser-73. The increased phosphorylation of c-Jun
observed in experiments using JNK2 compared with JNK1 may
result from the phosphorylation of different sites by these
protein kinases. We therefore examined the sites of c-Jun
phosphorylation by JNK1 and JNK2 by phosphoamino acid
analysis and tryptic phosphopeptide mapping. Both protein
kinases were found to phosphorylate c-Jun exclusively on Ser
106 --
80 -A-
50 --
33 -1
28 -- JNK2
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Phosphorlmager analysis demonstrated that JNK2 binding was
approximately 10-fold greater than JNK1 binding.
The specificity of binding was examined by comparing the
interaction of JNK protein kinases with c-Jun and v-Jun. In
previous studies, it has been demonstrated that v-Jun has a
deletion in the 8 subregion of the activation domain that
markedly reduces binding to JNK protein kinases (2-4, 18, 36).
GST fusion proteins with c-Jun and v-Jun were immobilized on
GSH-agarose and incubated with cell extracts containing
epitope-tagged JNK1 or JNK2. The agarose beads were
washed, and the bound JNK protein kinases were detected by
Western blot analysis using monoclonal antibody M2. Figure
4B shows that v-Jun is defective in binding both JNK isoforms.
Together, these data demonstrate that JNK1 and JNK2 bind
to the NH2-terminal activation domain of c-Jun but not to
v-Jun. The increased c-Jun phosphorylation caused by JNK2
(Fig. 2) correlates with increased binding of c-Jun to JNK2
compared with JNK1 (Fig. 4A).
Selective complementation of a deficiency in HOG1 expres-
sion by JNK protein kinases. Comparison of the sequence of
human JNK1 with the GenBank database indicates that this
enzyme is similar to the S. cerevisiae MAP kinase HOG1 (18).
This similarity suggests that HOG1 and JNK protein kinases
may serve similar functions in yeast and mammalian cells,
JNK1 JNK2
FIG. 4. JNK protein kinases bind to the c-Jun NH2-terminal acti-
vation domain. (A) Labeled JNK1 and JNK2 were prepared by in vitro
translation in the presence of [35S]methionine. The binding of the JNK
proteins to the activation domain of c-Jun was measured by incubation
with GST-c-Jun immobilized on GSH-agarose. Control experiments to
investigate nonspecific interactions were performed with immobilized
GST. JNK present in the supernatant fraction and JNK bound to
GST-Jun or GST were analyzed by PAGE. An autoradiograph of the
dried gel is shown. Locations of molecular mass standards are shown
at the left in kilodaltons. (B) A soluble extract was prepared from cells
expressing epitope-tagged JNK1 or JNK2. The binding of the JNK
proteins was measured by incubation of the cell extracts with GST-c-
Jun or GST-v-Jun immobilized on GSH-agarose. JNK bound to c-Jun
or v-Jun was analyzed by Western blotting with monoclonal antibody
M2. Locations of molecular mass standards are shown at the left in
kilodaltons.
(Fig. 3A). The tryptic phosphopeptide maps of c-Jun phos-
phorylated by JNK1 and JNK2 were similar. The two phos-
phopeptides observed have previously been demonstrated to
correspond to the phosphorylation of c-Jun at Ser-63 and
Ser-73 (7, 18, 54, 65, 66). Together, these data demonstrate
that JNK1 and JNK2 phosphorylate the same sites within the
NH2-terminal activation domain of c-Jun.
JNK protein kinases bind to the NH2-terminal activation
domain of c-Jun. We have previously demonstrated that JNK1
binds to the activation domain of c-Jun (18). The higher
protein kinase activity of JNK2 (Fig. 2) may therefore reflect
the increased binding of this isoform to c-Jun compared with
JNK1. We therefore examined the association of both JNK
isoforms with c-Jun. Labeled JNK1 and JNK2 prepared by in
vitro translation were incubated with GST or GST-Jun immo-
bilized on GSH-agarose. The bound JNK proteins were de-
tected after extensive washing by SDS-PAGE and autoradiog-
raphy. Figure 4A shows that both JNK isoforms bound to
GST-Jun but failed to bind to GST. Interestingly, only the
full-length JNK protein kinases obtained from the in vitro
translation were found to bind to GST-Jun. Quantitation by
JNK1
JNK2
FIG. 5. A deficiency in the expression of the MAP kinase HOG1 in
S. cerevisiae is complemented by human JNK1. Yeast cells lacking the
protein kinase HOG1 were transformed with an empty expression
vector (-) and spread on agar plates supplemented without (control)
or with 0.9 M NaCl (osmotic stress). Other cultures of yeast cells were
transformed with plasmid vectors encoding HOG1, JNK1, and JNK2.
Photographs of representative plates showing the growth of yeast
colonies are presented.
A.
Control OsmoticStre-ss
HOG1
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FIG. 6. TNF activates JNK1 and JNK2. HeLa cells were incubated
with 10 ng of TNF-a per ml for 15 min at 370C. JNK protein kinases
were isolated by immunoprecipitation with a polyclonal JNK antibody.
The protein kinase activity in the immune complexes was detected by
using an in-gel assay in the absence (control) and presence of the
substrate c-Jun. Locations of molecular mass standards are shown at
the left in kilodaltons.
respectively. To test this hypothesis, we examined whether
human JNK1 or JNK2 is able to complement a deficiency in
HOG1 expression. Yeast cells lacking HOG1 (null mutant
hogl-Al) are sensitive to osmotic stress and do not grow on
high-osmolarity media (15). Transfection of the hogl-Al mu-
tant with an expression vector encoding HOG1 rescues this
growth defect (Fig. 5). The hogl-Al mutant was not rescued by
transfection with an expression vector encoding the human
MAP kinase ERK2 (25). However, the hogl-Al mutant was
rescued when the cells were transfected with a JNK1 expres-
sion vector (Fig. 5). The specificity of the complementation by
JNK1 was confirmed by the demonstration that catalytically
inactive JNK1 (Thr-183-Pro-Tyr-185) substituted with Ala-
183-Pro-Phe-185 [18]) did not complement the hogl-Al mu-
tant (25). The complementation by wild-type JNK1 indicates
that this kinase can functionally substitute for HOG1 in yeast
cells (25). In contrast, it was found that JNK2 did not
complement the hogl-Al mutant (Fig. 5). Control experiments
using Western blot analysis demonstrated that both JNK
isoforms were expressed in yeast cells. The lack of complemen-
tation by JNK2 therefore reflects a difference in the properties
of JNK1 and JNK2.
Together, these data demonstrate that human JNK1 (but
not JNK2) is able to substitute for the HOG1 protein kinase in
yeast cells. This difference in complementation provides evi-
dence that the in vivo functions of JNK1 and JNK2 are distinct.
This conclusion is consistent with the observation that these
JNK isoforms do not have identical biochemical properties
(Fig. 2 and 4).
TNF activates the JNK protein kinase signal transduction
pathway. UV radiation causes potent activation of JNK pro-
tein kinases (Fig. 2). In contrast, the JNK signal transduction
pathway is only modestly activated by growth factors (e.g.,
EGF), activated Ha-Ras, and phorbol ester (18). A significant
question therefore concerns the identity of physiological in-
ducers of the JNK protein kinase pathway. As JNK activates
c-Jun, candidate inducers of the JNK pathway include agents
that cause sustained induction of c-Jun, such as the proinflam-
matory cytokine TNF-ot (14). We therefore tested the hypoth-
esis that TNF-ot causes JNK activation.
We examined JNK activation in HeLa cells treated with
20-
15
n 10
'05
0.
0 1.25 2.5 5 10 20
Concentration (nglml)
FIG. 7. Dose response of TNF-activated JNK protein kinase activ-
ity. HeLa cells were incubated for 15 min with different concentrations
of TNF-a at 37°C. JNK protein kinases were isolated by immunopre-
cipitation with a polyclonal JNK antibody. The protein kinase activity
in the immune complexes was measured by using recombinant c-Jun as
a substrate. The c-Jun was isolated by SDS-PAGE and visualized by
autoradiography. The extent of phosphorylation was measured with a
Phosphorlmager and is presented in arbitrary (Phosphorlmager) units.
TNF-a. The JNK protein kinases were isolated by immuno-
precipitation with a polyclonal JNK antibody, and protein
kinase activity in the immunoprecipitates was examined after
SDS-PAGE using an in-gel protein kinase assay with c-Jun as
a substrate. It was found that TNF-ao activated both the 46-kDa
JNK1 and 55-kDa JNK2 protein kinases (Fig. 6).
The effect of TNF-ot concentration on JNK activation was
examined in an immune-complex protein kinase assay with the
substrates c-Jun and [-y-32P]ATP. JNK activation was observed
when the HeLa cells were incubated with 1.25 ng of TNF-at per
ml (Fig. 7). A further increase in JNK activateon was found
when the cells were incubated with higher concentrations of
TNF-a. The time course of JNK activation was investigated in
experiments using HeLa cells incubated with 10 ng of TNF-a
per ml. A rapid and marked increase in JNK activity within 15
min of treatment with TNF-a was observed (Fig. 8). JNK
activity then declined to control levels 30 min after TNF-at
treatment. A lower but sustained increase in JNK activity was
observed at later times of TNF-at treatment. Together, these
data establish that the JNK protein kinase pathway is activated
by the proinflammatory cytokine TNF-a.
DISCUSSION
Signal transduction by proinflammatory cytokines. One
important action of proinflammatory cytokines is the regula-
tion of gene expression. TNF (and IL-1) induce the expression
of multiple cytokines, such as colony-stimulating factors, IL-2,
IL-6, IL-8, hepatocyte growth factor, TGF-a, nerve growth
factor, P-endorphin, and Gro-related factors (23, 32, 33, 41, 52,
58, 67, 78). TNF has also been shown to induce IL-1 expression
(27). Increased expression of proteins encoded by immediate-
early genes (e.g., c-Jun), cytokine receptors (e.g., IL-2 recep-
tor), growth factor receptors (e.g., the EGF receptor), major
histocompatibility complex (classes I and II), and collagenase
have been reported (14, 42, 58, 61). These changes in gene
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FIG. 8. Time course of JNK protein kinase activation by TNF.
HeLa cells were incubated with 10 ng of TNF-a per ml for different
times at 370C. JNK protein kinases were isolated by immunoprecipi-
tation with a polyclonal JNK antibody. The protein kinase activity in
the immune complexes was measured by using recombinant c-Jun as a
substrate. The c-Jun was isolated by SDS-PAGE and visualized by
autoradiography. The extent of phosphorylation was measured with a
Phosphorlmager and is presented in arbitrary (Phosphorlmager) units.
expression are mediated by the regulation of several transcrip-
tion factors. Indeed, effects of TNF and IL-1 on AP-1 (14, 50,
51), NF-KB (12, 39, 63), and C/EBP (5) have been described.
Recent studies have established a primary role for increased
AP-1 activity. Examples include the increased expression of
IL-2 (51), P-endorphin (23), c-Jun (50), the monocyte che-
moattractant JE (32), and the hyaluronan-binding protein
TSG6 (45). Together, these data demonstrate that AP-1 is a
physiologically significant target of the signal transduction
pathway activated by proinflammatory cytokines.
Homodimers of c-Jun or heterodimers of c-Jun with partner
proteins (e.g., c-Fos) bind to AP-1 sites (1, 43). Significantly,
the proinflammatory cytokines TNF and IL-1 cause a marked
increase in c-Jun expression (14, 51). The increased expression
of c-Jun is mediated by two cis-acting elements (AP-1 sites) in
the c-Jun promoter (50). This observation indicates that the
induction of c-Jun expression is dependent on the activation of
preexisting complexes of the AP-1 transcription factor (38).
One mechanism of activation is mediated by the phosphoryla-
tion of the NH2-terminal activation domain of c-Jun (10).
Indeed, detailed studies have demonstrated that the phosphor-
ylation of c-Jun within the NH2-terminal domain at Ser-63 and
Ser-73 causes increased transcriptional activity (54, 65, 66).
These regulatory sites of phosphorylation are substrates for
JNK protein kinases (36). Two JNK protein kinase isoforms
(46 and 55 kDa) have been identified in HeLa cells (36).
Recently, we molecularly cloned the 46-kDa isoform, JNK1
(18). Here, we describe the cloning of the 55-kDa isoform,
JNK2.
As JNK protein kinases phosphorylate sites on c-Jun that
increase transcriptional activity, JNK activation provides a
signaling mechanism that regulates AP-1. Thus, the increased
AP-1 activity observed in TNF-treated cells may be mediated
by the JNK signal transduction pathway. Consistent with this
hypothesis, incubation of cells with TNF caused a marked
increase in JNK protein kinase activity (Fig. 6). Interestingly,
JNK activation was also observed when cells were incubated
with IL-1 (17a).
Regulation of the JNK group of protein kinases. The JNK
group of protein kinases includes the 46-kDa JNK1 and the
55-kDa JNK2 isoforms (Fig. 1). Rat homologs of human JNK1
and JNK2 have recently been reported as a and -y SAPK (44).
The JNK group of protein kinases are distantly related to the
MAP kinases ERK1 and ERK2 (18). One significant similarity
between ERK and JNK is that activation requires dual phos-
phorylation at Thr and Tyr within subdomain VIII (18).
Interestingly, the phosphorylation motif present in JNK (Thr-
Pro-Tyr) is distinct from that ofERK (Thr-Glu-Tyr). Similarly,
the kinase kinases that activate JNK and ERK are distinct (18).
This finding implies that JNK and ERK are located within
separate signal transduction pathways. Thus, UV radiation
causes potent activation of JNK and only modest changes in
ERK activity (18). In contrast, EGF, activated Ha-Ras, and
phorbol ester cause marked ERK activation but only a small
increase in JNK activity (18). Here we demonstrate that the
JNK group of protein kinases are activated by the proinflam-
matory cytokine TNF. A similar conclusion has recently been
reported by Kyriakis et al. (44).
It is possible that JNK1 and JNK2 have redundant functions
in the cell. However, the observation that JNK1, but not JNK2,
complements a defect in the expression of the HOG1 MAP
kinase in S. cerevisiae demonstrates that these JNK isoforms
have distinct properties in vivo. Evidence for distinct functions
of JNK1 and JNK2 was also obtained by comparison of the in
vitro biochemical properties of these JNK isoforms. Thus, the
binding of c-Jun to JNK2 was significantly greater than the
binding to JNK1 (Fig. 4). Similarly, JNK2 caused greater
phosphorylation of c-Jun than did JNK1 (Fig. 2). The struc-
tural differences between JNK1 and JNK2 that may account
for these properties include (i) changes in the protein kinase
domain and (ii) the divergent COOH-terminal sequences (Fig.
1B).
Together, these data suggest that the catalytic activity of
JNK2 is greater than that of JNK1. However, it is also possible
that these data reflect a difference in the substrate specificity of
these JNK isoforms. Thus, c-Jun may be a preferential physi-
ological substrate for JNK2, while JNK1 targets a different
substrate. The identification of additional JNK substrates will
be required to test this hypothesis. Although it is likely that
several substrates for JNK protein kinases exist, at present
c-Jun is the only substrate that has been identified (18, 44). An
important goal for future studies will be to identify additional
JNK substrates. A comparison of the phosphorylation of these
substrates by JNK1 and JNK2 will be necessary to resolve
whether the difference in c-Jun phosphorylation by these
isoforms is the result of a difference in catalytic activity or
substrate specificity.
Conclusions. The JNK protein kinase pathway is activated
by exposure of cells to several forms of environmental stress,
including UV radiation and proinflammatory cytokines. TNF
and UV radiation have been demonstrated to cause cell cycle
growth arrest and apoptosis. The role of JNK activation in
these processes has not been established. However, JNK may
be a component of a signal transduction pathway that leads to
altered expression of stress-related genes. Thus, JNK activa-
tion may occur in response to exposure to several forms of
environmental stress.
ACKNOWLEDGMENTS
M. Gustin is thanked for providing plasmids and yeast strains. M.
Dickens is thanked for preparing the JNK antisera. M. Wysk and Z.
Galcheva-Gargova provided advice about screening cDNA libraries
MOL. CELL. BIOL.
81
 at UNIV O
F M
ASS M
ED SCH on August 15, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
JNK1 AND JNK2 PROTEIN KINASES 8383
and complementation assays, respectively. The technical assistance of
I.-H. Wu is greatly appreciated. The excellent secretarial assistance of
M. Shepard is acknowledged.
This study was supported by a grant from the National Cancer
Institute. R.J.D. is an Investigator of the Howard Hughes Medical
Institute.
REFERENCES
1. Abate, C., and T. Curran. 1990. Encounters with Fos and Jun on
the road to AP-1. Semin. Cancer Biol. 1:19-26.
2. Adler, V., C. C. Franklin, and A. S. Kraft. 1992. Phorbol esters
stimulate the phosphorylation of c-Jun but not v-Jun: regulation by
the N-terminal delta domain. Proc. Natl. Acad. Sci. USA 89:5341-
5345.
3. Adler, V., A. Polotskaya, F. Wagner, and A. S. Kraft. 1992.
Affinity-purified c-Jun amino-terminal protein kinase requires
serine/threonine phosphorylation for activity. J. Biol. Chem. 267:
17001-17005.
4. Adler, V., T. Unlap, and A. S. Kraft. 1994. A peptide encoding the
c-Jun 8 domain inhibits the activity of a c-jun amino terminal
protein kinase. J. Biol. Chem. 269:11186-11191.
5. Akira, S., J. Isshiki, T. Sugita, 0. Tanabe, S. Kinoshita, Y. Nishio,
T. Nakajima, T. Hirano, and T. Kishimoto. 1990. A nuclear factor
for IL-6 expression (NF-IL-6) is a member of the C/EBP family.
EMBO J. 9:1897-1906.
6. Andersson, S., D. L. Davis, H. Dahlback, H. Jornvall, and D. W.
Russell. 1989. Cloning, structure, and expression of the mitochon-
drial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosyn-
thetic enzyme. J. Biol. Chem. 264:8222-8229.
7. Baker, S. J., T. K. Kerppola, D. Luk, M. T. Vandenberg, D. R
Marshak, T. Curran, and C. Abate. 1992. Jun is phosphorylated by
several protein kinases at the same sites that are modified in
serum-stimulated fibroblasts. Mol. Cell. Biol. 12:4694-4705.
8. Banner, D. W., A. D'Arcy, W. Janes, R. Gentz, H.-J. Schoenfeld, C.
Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of
the soluble human 55 kDa TNF receptor-human TNF-P complex:
implications for TNF receptor activation. Cell 73:431-445.
9. Beutler, B., and A. Cerami. 1988. Tumor necrosis, cachexia, shock
and inflammation: a common mediator. Annu. Rev. Biochem.
57:505-518.
10. Binetruy, B., T. Smeal, and M. Karin. 1991. Ha-Ras augments
c-Jun activity and stimulates phosphorylation of its activation
domain. Nature (London) 351:122-127.
11. Bird, T. A., and J. Saklatvala. 1989. IL-1 and TNF transmodulate
epidermal growth factor receptors by a protein kinase C-indepen-
dent mechanism. J. Immunol. 142:126-133.
12. Bomsztyk, K., B. Toivola, D. W. Emery, J. W. Rooney, S. K. Dower,
N. A. Rachie, and C. H. Sibley. 1990. Role of cAMP in interleukin-
1-induced kappa light chain gene expression in murine B cell line.
J. Biol. Chem. 265:9413-9417.
13. Brakebusch, C., Y. Nophar, 0. Kemper, H. Engelmann, and D.
Wallach. 1992. Cytoplasmic truncation of the p55 tumor necrosis
factor (TNF) receptor abolishes signaling, but not the induced
shedding of the receptor. EMBO J. 11:943-950.
14. Brenner, D. A., M. O'Hara, P. Angel, M. Chojkier, and M. Karin.
1989. Prolonged activation ofjun and collagenase genes by tumour
necrosis factor-a. Nature (London) 337:661-663.
15. Brewster, J. L., T. de Valoir, N. D. Dwyer, E. Winter, and M. C.
Gustin. 1993. An osmosensing signal transduction pathway in
yeast. Science 259:1760-1763.
16. Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B.
Williamson. 1975. An endotoxin-induced serum factor that causes
necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666-3670.
17. Davis, R J. 1993. The mitogen-activated protein kinase signal
transduction pathway. J. Biol. Chem. 268:14553-14556.
17a.DeNrard, B., and R. Davis. Unpublished data.
18. Derijard, B., M. Hibi, I.-H. Wu, T. Barrett, B. Su, T. Deng, M.
Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by
UV light and Ha-Ras that binds and phosphorylates the c-Jun
activation domain. Cell 76:1025-1037.
19. Devary, Y., R A. Gottlieb, L. F. Lau, and M. Karin. 1991. Rapid
and preferential activation of the c-jun gene during the mamma-
lian UV response. Mol. Cell. Biol. 11:2804-2811.
20. Dressier, K. A., S. Mathias, and R N. Kolesnick. 1992. Tumor
necrosis factor-alpha activates the sphingomyelin signal transduc-
tion pathway in a cell-free system. Science 255:1715-1718.
21. Engelmann, H., H. Holtmann, C. Brakebusch, Y. S. Avni, I. Sarov,
Y. Nophar, E. Hadas, 0. Leitner, and D. Wallach. 1990. Antibod-
ies to a soluble form of a tumor necrosis factor (TNF) receptor
have TNF-like activity. J. Biol. Chem. 265:14497-14504.
22. Espevik, T., M. Brockhaus, H. Loetscher, U. Nonstad, and R.
Shalaby. 1990. Characterization of binding and biological effects
of monoclonal antibodies against a human tumor necrosis factor
receptor. J. Exp. Med. 171:415-426.
23. Fagarasan, M., F. Aiello, K. Muegge, S. K. Durum, and J. Axelrod.
1990. Interleukin 1 induces 3-endorphin secretion via Fos and Jun
in At-20 pituitary cells. Proc. Natl. Acad. Sci. USA 87:7871-7874.
24. Fiers, W. 1991. Tumor necrosis factor: characterization at the
molecular, cellular and in vivo level. FEBS Lett. 285:199-215.
25. Galcheva-Gargova, Z., B. Der-ijard, I.-H. Wu, and R. J. Davis.
1994. An osmosensing signal transduction pathway in mammalian
cells. Science 265:806-808.
26. Goeddel, D. V., B. B. Aggarwal, P. W. Gray, D. W. Leung, G. E.
Nedwin, M. A. Palladino, J. S. Patton, D. Pennica, H. M. Shepard,
B. J. Sugarman, and G. H. W. Wong. 1986. Tumor necrosis factors:
gene structure and biological activities. Cold Spring Harbor Symp.
Quant. Biol. 51:597-609.
27. Gorospe, M., S. Kumar, and C. Baglioni. 1993. Tumor necrosis
factor increases stability of interleukin-1 mRNA by activating
protein kinase C. J. Biol. Chem. 268:6214-6220.
28. Guesdon, F., N. Freshney, R J. Waller, L. Rawlinson, and J.
Saklatvala. 1993. Interleukin 1 and tumor necrosis factor stimu-
late two novel protein kinases that phosphorylate the heat shock
protein hsp27 and beta-casein. J. Biol. Chem. 268:4236-4243.
29. Guy, G. R., J. Cairns, S. B. Ng, and Y. H. Tan. 1993. Inactivation
of a redox-sensitive protein phosphatase during the early events of
tumor necrosis factor/interleukin 1 signal transduction. J. Biol.
Chem. 268:2141-2148.
30. Guy, G. R., X. Cao, S. P. Chua, and Y. H. Tan. 1992. Okadaic acid
mimics multiple changes in early protein phosphorylation and
gene expression induced by tumor necrosis factor or interleukin-1.
J. Biol. Chem. 267:1846-1852.
31. Guy, G. R., S. P. Chua, N. S. Wong, S. B. Ng, and Y. H. Tan. 1991.
Interleukin 1 and tumor necrosis factor activate common multiple
protein kinases in human fibroblasts. J. Biol. Chem. 266:14343-
14352.
32. Hanazawa, S., A. Takeshita, S. Amano, T. Semba, T. Nirazuka, H.
Katoh, and S. Kitano. 1993. Tumor necrosis factor-a induces
expression of monocyte chemoattractant JE via fos and jun genes
in clonal osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268:9526-
9532.
33. Hattori, A., E. Tanaka, K. Murase, N. Ishida, Y. Chatani, M.
Tsujimoto, K. Hayashi, and M. Kohno. 1993. Tumor necrosis
factor stimulates the synthesis and secretion of biologically active
nerve growth factor in non-neuronal cells. J. Biol. Chem. 268:
2577-2582.
34. Heller, R A., K. Song, and N. Fan. 1993. Cytotoxicity by tumor
necrosis factor is mediated by both p55 and p70 receptors. Cell
73:216.
35. Heller, R. A., K. Song, N. Fan, and D. J. Chang. 1992. The p70
tumor necrosis factor receptor mediates cytotoxicity. Cell 70:47-
56.
36. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993.
Identification of an oncoprotein- and UV-responsive protein
kinase that bind and potentiate the c-Jun activation domain.
Genes Dev. 7:2135-2148.
37. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease.
1989. Site-directed mutagenesis by overlap extension using the
polymerase chain reaction. Gene 77:51-59.
38. Hunter, T., and M. Karin. 1992. The regulation of transcription by
phosphorylation. Cell 70:375-387.
39. Iwasaki, T., Y. Uehara, L. Graves, N. Rachie, and K. Bromsztyl.
1992. Herbimycin A blocks IL-1-induced NF-KB DNA binding
activity in lymphoid cell lines. FEBS Lett. 298:240-244.
40. Joseph, C. K., H.-S. Byun, R Bittman, and R N. Kolesnick. 1993.
Substrate recognition by ceramide-activated protein kinase. J.
VOL. 14, 1994
 at UNIV O
F M
ASS M
ED SCH on August 15, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
8384 SLUSS ET AL.
Biol. Chem. 268:20002-20006.
41. Joshi-Barve, S. S., V. V. Rangnekar, S. F. Sells, and V. M.
Rangnekar. 1993. Interleukin-1 inducible expression of gro-P via
NF-KB activation is dependent upon tyrosine kinase signaling. J.
Biol. Chem. 268:18018-18029.
42. Kalthoff, H., C. Roeder, M. Brockhaus, H.-G. Thiele, and W.
Schmiegel. 1993. Tumor necrosis factor (TNF) up-regulates the
expression of p75 but not p55 TNF receptors, and both receptors
mediate, independently of each other, up-regulation of transform-
ing growth factor-a and epidermal growth factor receptor
mRNA. J. Biol. Chem. 268:2762-2766.
43. Karin, M. 1992. Signal transduction from cell surface to nucleus in
development and disease. FASEB J. 6:2581-2590.
44. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie,
M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-
activated protein kinase subfamily of c-Jun kinases. Nature (Lon-
don) 369:156-160.
45. Lee, T. H., L. Klampfer, T. B. Shows, and J. Vilcek. 1993.
Transcriptional regulation of TSG6, a tumor necrosis factor- and
interleukin-1-inducible primary response gene coding for a se-
creted hyaluronan-binding protein. J. Biol. Chem. 268:6154-6160.
46. Lenardo, M. J., and D. Baltimore. 1989. NF-kappa B: a pleiotropic
mediator of inducible and tissue-specific gene control. Cell 58:
227-229.
47. Loetscher, H., D. Stueber, D. Banner, F. Mackay, and W. Less-
lauer. 1993. Human tumor necrosis factor alpha (TNF-alpha)
mutants with exclusive specificity for the 55-kDa and 75-kDa TNF
receptors. J. Biol. Chem. 268:26350-26357.
48. Mathias, S., K. A. Dresser, and R. N. Kolesnick. 1991. Characteriza-
tion of a ceramide-activated protein kinase: stimulation by tumor
necrosis factor alpha. Proc. Natl. Acad. Sci. USA 88:10009-10013.
49. Mathias, S., A. Younes, C.-C. Kan, I. Orlow, C. Joseph, and R. N.
Kolesnick. 1993. Activation of the sphingomyelin signaling path-
way in intact EL4 cells and in a cell-free system by IL-1p. Science
259:519-522.
50. Muegge, K., M. Vila, G. L. Gusella, T. Musso, P. Herrlich, B.
Stein, and S. K. Durum. 1993. Interleukin-1 induction of the c-jun
promoter. Proc. Natl. Acad. Sci. USA 90:7054-7058.
51. Muegge, K., T. M. Williams, J. Kant, M. Karin, R. Chiu, A.
Schmidt, U. Siebenlist, H. A. Young, and S. K. Durum. 1989.
Interleukin-1 costimulatory activity on the interleukin-2 promoter
via AP-1. Science 246:249-251.
52. Mukaida, N., Y. Mahe, and K. Matsushima. 1990. Cooperative
interaction of nuclear factor-KB and cis-regulatory enhancer bind-
ing protein-like factor binding elements in activating the interleu-
kin-8 gene by pro-inflammatory cytokines. J. Biol. Chem. 265:
21128-21133.
53. Ostrowski, J., K. E. Meier, T. H. Stanton, L. L. Smith, and K.
Bomsztyk. 1988. Interferon--y and interleukin-la induce transient
translocation of protein kinase C activity to membranes in a B
lymphoid cell line. J. Biol. Chem. 263:13786-13790.
54. Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R.
Woodgett. 1991. Phosphorylation of c-Jun mediated by MAP
kinases. Nature (London) 353:670-674.
55. Qwarnstorm, E. E., S. A. MacFarlene, R. C. Page, and S. K. Dower.
1991. Interleukin 11 induces rapid phosphorylation and redistribu-
tion of talin: a possible mechanism for modulation of fibroblast focal
adhesion. Proc. Natl. Acad. Sci. USA 88:1232-1236.
56. Rachie, N. A., R. Seger, M. A. Valentine, J. Ostrowski, and K.
Bomsztyk. 1993. Identification of an inducible 85 kDa nuclear
protein kinase. J. Biol. Chem. 268:22143-22149.
57. Raines, M. A., R. N. Kolesnick, and D. W. Golde. 1993. Sphingo-
myelinase and ceramide activate mitogen-activated protein kinase
in myeloid HL-60 cells. J. Biol. Chem. 268:14572-14575.
58. Rangnekar, V. V., S. Waheed, and V. M. Rangnekar. 1992.
Interleukin-1 inducible tumor growth arrest is characterized by
activation of cell type-specific "early" gene expression programs. J.
Biol. Chem. 267:6240-6248.
59. Ruddle, N. H., and B. H. Waksman. 1967. Cytotoxicity effect of
lymphocyte-antigen interaction in delayed hypersensitivity. Sci-
ence 157:1060-1062.
60. Schlessinger, J. 1988. Signal transduction by allosteric receptor
oligomerization. Trends Biochem. Sci. 13:443-447.
61. Schonthal, A., M. Buscher, P. Angel, H. J. Rahmsdorf, H. Ponta,
K. Hattori, R. Chiu, M. Karin, and P. Herrlich. 1989. The Fos and
Jun/AP-1 proteins are involved in the downregulation of Fos
transcription. Oncogene 4:629-636.
62. Seth, A., F. A. Gonzalez, S. Gupta, D. L. Raden, and R. J. Davis.
1992. Signal transduction within the nucleus by mitogen-activated
protein kinase. J. Biol. Chem. 267:24796-24804.
63. Shirakawa, F., M. Chedid, J. Suttles, B. A. Pollock, and S. B.
Mizel. 1989. Interleukin 1 and cAMP induce kappa immunoglob-
ulin ight chain expression via activation of an NF-kappa B-like
DNA-binding protein. Mol. Cell. Biol. 9:959-964.
64. Shirakawa, F., U. Yamashita, M. Chedid, and S. B. Mizel. 1988.
cAMP-an intracellular second messenger for interleukin-1. Proc.
Natd. Acad. Sci. USA 85:8201-8205.
65. Smeal, T., B. Binetruy, D. Mercola, B. A. Grover, G. Heidecker,
U. R. Rapp, and M. Karin. 1992. Oncoprotein-mediated signalling
cascade stimulates c-Jun activity by phosphorylation of serines 63
and 73. Mol. Cell. Biol. 12:3507-3513.
66. Smeal, T., B. Binetruy, D. A. Mercola, M. Birrer, and M. Karin.
1991. Oncogenic and transcriptional cooperation with Ha-Ras
requires phosphorylation of c-Jun on serines 63 and 73. Nature
(London) 354:494-496.
67. Tamura, M., N. Arakaki, H. Tsubouchi, H. Takada, and Y.
Daikuhara. 1993. Enhancement of human hepatocyte growth
factor production by interleukin-lot and-1,B and tumor necrosis
factor-a by fibroblasts in culture. J. Biol. Chem. 268:8140-8145.
68. Tartaglia, L. A., T. M. Ayres, G. H. W. Wong, and D. V. Goeddel.
1993. A novel domain within the 55 kDa TNF receptor signals cell
death. Cell 74:845-853.
69. Tartaglia, L. A., and D. V. Goeddel. 1992. Tumor necrosis factor
receptor signaling: a dominant negative mutation suppresses the
activation of the 55-kDa tumor necrosis factor receptor. J. Biol.
Chem. 267:4304-4307.
70. Tartaglia, L. A., and D. V. Goeddel. 1992. Two TNF receptors.
Immunol. Today 13:151-153.
71. Tartaglia, L. A., D. Pennica, and D. V. Goeddel. 1993. Ligand
passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits
TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem.
268:18542-18548.
72. Tartaglia, L. A., M. Rothe, Y.-F. Hu, and D. V. Goeddel. 1993.
Tumor necrosis factor's cytotoxic activity is signaled by the p55
TNF receptor. Cell 73:213-216.
73. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynolds, M. A.
Palladino, and D. V. Goeddel. 1991. The two different receptors
for tumor necrosis factor mediate distinct cellular responses. Proc.
Natl. Acad. Sci. USA 88:9292-9296.
74. Vietor, I., P. Schwenger, W. Li, J. Schlessinger, and J. Vilcek. 1993.
Tumor necrosis factor-induced activation and increased tyrosine
phosphorylation of mitogen-activated protein (MAP) kinase in
human fibroblasts. J. Biol. Chem. 268:18994-18999.
75. Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mamma-
lian Ras interacts directly with the serine/threonine kinase Raf.
Cell 74:205-214.
76. Wiegmann, K., S. Schutze, E. Kampen, A. Himmler, T. Machleidt,
and M. Kronke. 1992. Human 55-kDa receptor for tumor necrosis
factor coupled to signal transduction cascades. J. Biol. Chem.
267:17997-18001.
77. Wong, G. H. W., L. A. Tartaglia, M. S. Lee, and D. V. Goeddel.
1992. Antiviral activity of tumor necrosis factor is signaled through
the 55-kDa type 1 TNF receptor. J. Immunol. 149:3550-3553.
78. Zhang, Y., J.-X. Lin, and J. Vilcek. 1990. Interleukin-6 induction
by tumor necrosis factor and interleukin-1 in human fibroblasts
involves activation of a nuclear factor binding to a KB-like
sequence. Mol. Cell. Biol. 10:3818-3823.
79. Zhang, Y., J. X. Lin, Y. K. Yip, and J. Vilcek. 1988. Enhancement
of cyclic AMP levels and of protein kinase activity by tumor
necrosis factor and interleukin-1 in human fibroblasts: role in the
induction of interleukin 6. Proc. Natl. Acad. Sci. USA 85:6802-
6805.
MOL. CELL. BIOL.
 at UNIV O
F M
ASS M
ED SCH on August 15, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
